PIK3CD and neoplasm: Oral treatment of parallel groups of mice with the p110δ-selective inhibitor, IC87114, which prevented tumour growth (Fig. 5a), significantly increased PTEN activity in tumour cells (Fig. 5d), indicating that a mechanism by which the p110δ inhibition suppresses the survival of tumour cells is via the increased PTEN activity.